Exagen Inc. XGN Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$20.17M-1.1% | -$19.95M-4.8% | -$19.04M-12.1% | -$16.98M-9.5% | -$15.51M-2.6% | ||
| $2.4M+11.0% | $2.16M+14.4% | $1.89M+24.9% | $1.51M-7.2% | $1.63M-7.7% | ||
| $469K+24.1% | $378K+30.8% | $289K+46.7% | $197K+23.9% | $159K+3.2% | ||
| —— | —— | —— | —— | —— | ||
| -$230K-648% | $42K-97.7% | $1.79M+499% | -$449K-121% | $2.19M+610% | ||
| $112K-55.4% | $251K— | —— | —— | —— | ||
| -$892K-12.6% | -$792K-56.2% | -$507K— | —— | —— | ||
| $26K+118% | -$147K+32.3% | -$217K+38.7% | -$354K— | —— | ||
| —— | —— | $641K-36.9% | $1.02M+16.0% | $876K+19.5% | ||
| -$1.13M-2.9% | -$1.1M-3.0% | -$1.06M-2.9% | -$1.03M-3.0% | -$1M-2.9% | ||
| —— | —— | —— | -$15.73M-3.0% | -$15.27M-12.0% | ||
| $756K+17.9% | $641K-13.7% | $743K+20.8% | $615K+13.5% | $542K+5.2% | ||
| —— | —— | —— | —— | $6K— | ||
| -$747K-19.3% | -$626K+15.1% | -$737K-21.0% | -$609K-13.6% | -$536K-4.1% | ||
| $653K+10.3% | $592K+38.6% | $427K+61.1% | $265K+531% | $42K— | ||
| —— | —— | —— | $18.78M+9,383% | $198K— | ||
| $593K+20.0% | $494K+16.5% | $424K+17.1% | $362K-17.9% | $441K-10.0% | ||
| $804K-7.5% | $869K0.0% | $869K+29.7% | $670K+931% | $65K— | ||
| $24.82M0.0% | $24.82M+0.9% | $24.6M+14.3% | $21.53M+3,534% | -$627K+5.4% | ||
| —— | —— | $13.62M+145% | $5.55M+135% | -$16.07M-11.2% | ||
| $3.44M+15.2% | $2.99M+18.6% | $2.52M+21.7% | $2.07M+22.7% | $1.69M-1.9% | ||
| $469K+24.1% | $378K+30.8% | $289K+46.7% | $197K+23.9% | $159K+3.2% | ||
| $1.44M+85.1% | $777K+55.4% | $500K+150% | $200K— | —— | ||
| $2.28M+7.5% | $2.12M+9.6% | $1.93M+10.9% | $1.74M+2.2% | $1.71M-1.0% | ||
| $112K-55.4% | $251K— | —— | —— | —— | ||
| -$1.13M-2.9% | -$1.1M-3.0% | -$1.06M-2.9% | -$1.03M-3.0% | -$1M-2.9% | ||
| —— | —— | $1.09M-7.1% | $1.17M-50.0% | $2.35M+31.5% | ||
| —— | —— | —— | —— | —— | ||
| $26K+118% | -$147K+32.3% | -$217K+38.7% | -$354K— | —— | ||
| —— | —— | —— | —— | $6K— | ||
| $593K+20.0% | $494K+16.5% | $424K+17.1% | $362K-17.9% | $441K-10.0% | ||
| $804K-7.5% | $869K0.0% | $869K+29.7% | $670K— | —— | ||
| $495K+24.4% | $398K— | —— | —— | —— | ||
| $653K+10.3% | $592K+11.3% | $532K+12.5% | $473K+14.5% | $413K+11.3% | ||
| -$79K-416% | $25K-96.5% | $714K+2.4% | $697K-23.1% | $906K+23.1% | ||
| —— | $3.28M+33.3% | $2.46M+50.0% | $1.64M+100% | $819.75K— | ||
| —— | —— | $3.11M+610% | $438K— | $0— | ||
| —— | —— | $641K-36.9% | $1.02M+16.0% | $876K+19.5% | ||
| -$1.13M-2.9% | -$1.1M-3.0% | -$1.06M-2.9% | -$1.03M-3.0% | -$1M-2.9% | ||
| $2.55M-21.0% | $3.23M0.0% | $3.23M+374% | $682K+0.7% | $677K— | ||
| —— | —— | —— | -$16.2M-3.4% | -$15.67M-11.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Exagen Inc. generate?
- Exagen Inc. (XGN) generated -$27.0M in operating cash flow over the trailing twelve months.
- What is Exagen Inc.'s free cash flow?
- After $756.0K of capital expenditures, Exagen Inc.'s free cash flow was -$27.6M over the trailing twelve months, down 96.9% year over year.
- Where does Exagen Inc.'s cash flow data come from?
- Every line is extracted from Exagen Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
